7.7: Chapter 7 References and Suggested Readings
- Page ID
- 45179
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)
( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\id}{\mathrm{id}}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\kernel}{\mathrm{null}\,}\)
\( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\)
\( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\)
\( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)
\( \newcommand{\vectorA}[1]{\vec{#1}} % arrow\)
\( \newcommand{\vectorAt}[1]{\vec{\text{#1}}} % arrow\)
\( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vectorC}[1]{\textbf{#1}} \)
\( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)
\( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)
\( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)Accad, M., & Francis, D. (2018). Does evidence based medicine adversely affect clinical judgment?. BMJ: British Medical Journal (Online), 362.
Agresti, A., Coull, B. A. (1998). Approximate Is Better than “Exact” for Interval Estimation of Binomial Proportions. The American Statistician, 52:119-126.
Altman, D. G. (1998). Confidence intervals for the number needed to treat. BMJ, 317(7168), 1309-1312.
Bender, R. (2001). Calculating confidence intervals for the number needed to treat. Controlled clinical trials, 22(2), 102-110.
Berry, D. A. (2008). The science of doping. Nature 454(7205):692-3.
Bewick, V., Cheek, L., Ball, J. (2003). Statistics review 8: Qualitative data – tests of association. Critical Care, 8:46-53.
Carling, C. L. L., Kristoffersen, D. T., Montori, V. M., Herrin, J., Schünemann, H. J., Treweek, S., Akl, E. A., Oxman, A. D. (2009). The Effect of Alternative Summary Statistics for Communicating Risk Reduction on Decisions about Taking Statins: A Randomized Trial. PLoS Medicine, 6(8): e1000134
Davies, H. T., Crombie, I. K., Tavakoli, M. (1998). When can odds ratios mislead? BMJ, 316: 989-991
Decker, R. C. (2008). A brief review of the basic principles of epidemiology, Chapter 2 in Field Epidemiology, 3rd edition, Gregg MB editor. Oxford University Press
de Vrieze, Jop. (2018) The metawars. Science 361: 1184-1188.
Fisher, G., Hunter, G. R., Gower, B. A. (2012). Aerobic exercise training conserves insulin sensitivity for 1 yr following weight loss in overweight women. J. Appl. Physiol., 112, 688-693.
Galinsky, A. M., Zelaya, C. E., Barnes, P. M., & Simile, C. (2022). Selected health conditions among native Hawaiian and Pacific Islander adults: United States, 2014. Cancer, 23, 2.
Gerstman, B. B. (2014). Basic biostatistics: Statistics for public health practice, 2nd ed. Jones & Bartlett Learning.
Gigerenzer, G. (2002). Calculated Risks: How to Know When Numbers Deceive You. Simon & Schuster.
Gray, M. W. (2002). Cramming for court: teaching statistics to litigators. ICOTS6: The Sixth International Conference on Teaching Statistics.
Hastings, D/. (2003). The Challenger Disaster. https://ocw.mit.edu/courses/engineering-systems-division/esd-10-introduction-to-technology-and-policy-fall-2006/readings/challenger.pdf.
Johnson, K. M. (2017). Using Bayes’ rule in diagnostic testing: a graphical explanation. Diagnosis, 4(3), 159-167.
Krebs, J. R. (2014). Risk, uncertainty and regulation. Philosophical Transactions. Series a, Mathematical, Physical, and Engineering Sciences. 369: 4842-52. PMID 22042900 DOI: 10.1098/rsta.2011.0174
Leucuta, D. C., Călinici, T., Drugan, T., Istrate, D., & Achimas, A. (2014). Graphical User Interface Extension in R Commander for Evidence Based Medicine Indicators. Applied Medical Informatics., 35(3), 11-16.
LIPID Study Group (1998). Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. NEJM, 339:1349-1357.
Masic, I., Miokovic, M., & Muhamedagic, B. (2008). Evidence based medicine–new approaches and challenges. Acta Informatica Medica, 16(4), 219.
Maugh, T.H., II. (1995, November 16). Anti-Cholesterol Drug Cuts Heart Attacks, Study Shows : Health: Pravastatin reduced risks for healthy men, research finds. Experts predict new era in prevention. Los Angeles Times, Retrieved from https://www.latimes.com/archives/la-...794-story.html.
Park, D. I., Ryu, S., Kim, Y. H., Lee, S. H., Lee, C. K., Eun, C. S., & Han, D. S. (2010). Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. American Journal of Gastroenterology, 105(9), 2017-2025.
Parikh, R., Parikh, S., Arun, E., Thomas, R. (2009). Likelihood ratios: Clinical application in day-to-day practice. Indian Journal of Opthamology 57(3): 217–221.
Rice, B., Janssen, I., Hudson, R., Ross, R. (1999). Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 22:684-691
Schechtman, E. (2002). Odds ratio, relative risk, absolute risk reduction, and the number needed to treat—which of these should we use?. Value in health, 5(5), 431-436.
Sibbald, B., & Roland, M. (1998). Understanding controlled trials. Why are randomised controlled trials important? BMJ 316(7126), 201.
Skolbekken, J. A. (1998). Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ, 316(7149), 1956-1958.
Smits, N. (2010). A note on Youden’s J and its cost ratio. BMC medical research methodology, 10(1), 1-4.
Sylvester, R. J., Canfield, S. E., Lam, T. B., Marconi, L., MacLennan, S., Yuan, Y., … & Hernandez, V. (2017). Conflict of evidence: resolving discrepancies when findings from randomized controlled trials and meta-analyses disagree. European urology, 71(5), 811-819.
Tamhane, A. R., Westfall, A. O., Burkholder, G. A., & Cutter, G. R. (2016). Prevalence odds ratio versus prevalence ratio: choice comes with consequences. Statistics in medicine, 35(30), 5730-5735.
US Department of Health and Human Services. (2013). Principles of Epidemiology in Public Health Practice, Third Edition: An Introduction to Applied Epidemiology and Biostatistics. Atlanta, Georgia, USA. Available on the website: http://www.cdc.gov/ophss/csels/dsepd/SS1978.
Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3(1), 32-35.